![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...
Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program PR Newswire STOCKHOLM, May 23, 2024 STOCKHOLM, May 23, 2024 /PRNewswire/ -- Medivir AB (Nasdaq...
– The phase 1/2 clinical trial of TNG348, a USP1 inhibitor, is being terminated due to toxicity observed in the initial study cohorts – – Cash runway extended into 2027, PRMT5 and CoREST clinical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.16 | -1.61453077699 | 9.91 | 10.07 | 8.93 | 1217071 | 9.73902273 | CS |
4 | 0.61 | 6.67396061269 | 9.14 | 10.13 | 7.95 | 880214 | 9.27654676 | CS |
12 | 2.24 | 29.82689747 | 7.51 | 10.44 | 6.46 | 751433 | 8.55727192 | CS |
26 | -1.75 | -15.2173913043 | 11.5 | 13.005 | 6.46 | 667680 | 9.09689028 | CS |
52 | 6.46 | 196.352583587 | 3.29 | 13.03 | 2.88 | 1132009 | 8.51249402 | CS |
156 | 0.14 | 1.45681581686 | 9.61 | 18.84 | 2.47 | 538539 | 8.09700677 | CS |
260 | 0.14 | 1.45681581686 | 9.61 | 18.84 | 2.47 | 538539 | 8.09700677 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions